Here are three things to know.
1. President Trump’s list of imports that may be hit with the increased tariffs include ingredients used to produce insulin, epinephrine and antidepressants.
2. According to the FDA, China is one of the largest suppliers of ingredients for domestic prescription drug manufacturers.
3. “We are concerned that the proposed tariffs may lead to increased costs of manufacturing for generics and biosimilars and thus higher prescription drug prices for patients in the U.S.,” the Association for Accessible Medicines said in a statement.
More articles on business:
AI with an ROI — why natural language processing makes sense for healthcare
The future of the connected clinician
Amazon’s ad business could hit $20B threshold in 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.